• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于人工智能的用于抑制硬化蛋白的FDA批准的重新利用药物的3D-QSAR模型。

AI-based 3D-QSAR model of FDA-approved repurposed drugs for inhibiting sclerostin.

作者信息

Yadalam Pradeep Kumar, Anegundi Raghavendra Vamsi, Ramadoss Ramya, Shrivastava Deepti, Almufarrij Raha Ahmed Shamikh, Srivastava Kumar Chandan

机构信息

Department of Periodontics, Saveetha Dental College and Hospitals Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamil Nadu, India.

Department of Oral Biology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India.

出版信息

Technol Health Care. 2024;32(5):3007-3019. doi: 10.3233/THC-231358.

DOI:10.3233/THC-231358
PMID:39031396
Abstract

BACKGROUND

Wnt activation promotes bone formation and prevents bone loss. The Wnt pathway antagonist sclerostin and additional anti-sclerostin antibodies were discovered as a result of the development of the monoclonal antibody romosozumab. These monoclonal antibodies greatly increase the risk of cardiac arrest. Three-dimensional quantitative structure-activity relationships (3D-QSAR) predicts biological activities of ligands based on their three-dimensional features by employing powerful chemometric investigations such as artificial neural networks (ANNs) and partial least squares (PLS).

OBJECTIVE

In this study, ligand-receptor interactions were investigated using 3D-QSAR Comparative molecular field analysis (CoMFA). Estimates of steric and electrostatic characteristics in CoMFA are made using Lennard-Jones and Coulomb potentials.

METHODS

To identify the conditions necessary for the activity of these molecules, fifty Food and Drug Administration (FDA)-approved medications were chosen for 3D-QSAR investigations and done by CoMFA. For QSAR analysis, there are numerous tools available. This study employed Open 3D-QSAR for analysis due to its simplicity of use and capacity to produce trustworthy results. Four tools were used for the analysis on this platform: Py-MolEdit, Py-ConfSearch, and Py-CoMFA.

RESULTS

Maps that were generated were used to determine the screen's r2 (Coefficient of Multiple Determinations) value and q2 (correlation coefficient). These numbers must be fewer than 1, suggesting a good, trustworthy model. Cross-validated (q2) 0.532 and conventional (r2) correlation values of 0.969 made the CoMFA model statistically significant. The model showed that hydroxamic acid inhibitors are significantly more sensitive to the steric field than the electrostatic field (70%) (30%). This hypothesis states that steric (43.1%), electrostatic (26.4%), and hydrophobic (20.3%) qualities were important in the design of sclerostin inhibitors.

CONCLUSION

With 3D-QSAR and CoMFA, statistically meaningful models were constructed to predict ligand inhibitory effects. The test set demonstrated the model's robustness. This research may aid in the development of more effective sclerostin inhibitors that are synthesised using FDA-approved medications.

摘要

背景

Wnt激活可促进骨形成并预防骨质流失。Wnt通路拮抗剂硬化蛋白以及其他抗硬化蛋白抗体是在单克隆抗体罗莫单抗的研发过程中被发现的。这些单克隆抗体极大地增加了心脏骤停的风险。三维定量构效关系(3D-QSAR)通过运用强大的化学计量学研究方法,如人工神经网络(ANNs)和偏最小二乘法(PLS),基于配体的三维特征预测其生物活性。

目的

在本研究中,使用3D-QSAR比较分子场分析(CoMFA)研究配体-受体相互作用。CoMFA中的空间和静电特征估计是使用 Lennard-Jones和库仑势进行的。

方法

为确定这些分子活性所需的条件,选择了五十种美国食品药品监督管理局(FDA)批准的药物进行3D-QSAR研究,并通过CoMFA完成。对于QSAR分析,有许多可用工具。本研究采用Open 3D-QSAR进行分析,因其使用简单且能够产生可靠结果。在该平台上使用了四种工具进行分析:Py-MolEdit、Py-ConfSearch和Py-CoMFA。

结果

生成的图谱用于确定筛选的r2(多重决定系数)值和q2(相关系数)。这些数值必须小于1,表明是一个良好、可靠的模型。交叉验证(q2)为0.532,传统(r2)相关值为0.969,使得CoMFA模型具有统计学意义。该模型表明,异羟肟酸抑制剂对空间场的敏感性明显高于静电场(70%)(30%)。该假设指出,空间(43.1%)、静电(26.4%)和疏水(20.3%)性质在硬化蛋白抑制剂的设计中很重要。

结论

通过3D-QSAR和CoMFA构建了具有统计学意义的模型来预测配体抑制作用。测试集证明了该模型的稳健性。本研究可能有助于开发使用FDA批准药物合成的更有效的硬化蛋白抑制剂。

相似文献

1
AI-based 3D-QSAR model of FDA-approved repurposed drugs for inhibiting sclerostin.基于人工智能的用于抑制硬化蛋白的FDA批准的重新利用药物的3D-QSAR模型。
Technol Health Care. 2024;32(5):3007-3019. doi: 10.3233/THC-231358.
2
CoMFA, CoMSIA and HQSAR Analysis of 3-aryl-3-ethoxypropanoic Acid Derivatives as GPR40 Modulators.作为 GPR40 调节剂的 3-芳基-3-乙氧基丙酸衍生物的 CoMFA、CoMSIA 和 HQSAR 分析。
Curr Drug Discov Technol. 2020;17(1):100-118. doi: 10.2174/1570163815666180829144431.
3
3D QSAR and molecular docking studies of benzimidazole derivatives as hepatitis C virus NS5B polymerase inhibitors.作为丙型肝炎病毒NS5B聚合酶抑制剂的苯并咪唑衍生物的3D QSAR和分子对接研究
J Chem Inf Model. 2008 Jan;48(1):42-55. doi: 10.1021/ci700266z. Epub 2007 Dec 13.
4
3D-QSAR comparative molecular field analysis on opioid receptor antagonists: pooling data from different studies.阿片受体拮抗剂的3D-QSAR比较分子场分析:整合来自不同研究的数据
J Med Chem. 2005 Mar 10;48(5):1620-9. doi: 10.1021/jm049117e.
5
Teaching and Learning Computational Drug Design: Student Investigations of 3D Quantitative Structure-Activity Relationships through Web Applications.计算药物设计的教学与学习:学生通过网络应用对三维定量构效关系的探究。
J Chem Educ. 2020 Jul 14;97(7):1922-1930. doi: 10.1021/acs.jchemed.0c00117. Epub 2020 Jun 23.
6
Three-dimensional quantitative structure activity relationship (QSAR) of cytotoxic active 3,5-diaryl-4,5-dihydropyrazole analogs: a comparative molecular field analysis (CoMFA) revisited study.细胞毒性活性3,5-二芳基-4,5-二氢吡唑类似物的三维定量构效关系(QSAR):一项重新审视的比较分子场分析(CoMFA)研究。
Chem Cent J. 2012 May 30;6(1):50. doi: 10.1186/1752-153X-6-50.
7
Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.基于三维定量构效关系比较分子场分析/比较分子相似性指数分析模型对尿激酶型纤溶酶原激活剂抑制剂结构要求的洞察。
J Med Chem. 2006 Jan 26;49(2):475-89. doi: 10.1021/jm050149r.
8
Improved 3D-QSAR Prediction by Multiple Conformational Alignments and Molecular Docking Studies to Design and Discover HIV-I Protease Inhibitors.通过多种构象排列和分子对接研究提高 3D-QSAR 预测,以设计和发现 HIV-I 蛋白酶抑制剂。
Curr HIV Res. 2021;19(2):154-171. doi: 10.2174/1570162X18666201119143457.
9
3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments.蛋白质酪氨酸磷酸酶1B抑制剂的3D QSAR研究:基于不同构象比对获得的3D QSAR模型之间的质量和预测能力比较。
J Chem Inf Model. 2006 Nov-Dec;46(6):2579-90. doi: 10.1021/ci600224n.
10
3D-QSAR of human immunodeficiency virus (I) protease inhibitors. III. Interpretation of CoMFA results.人类免疫缺陷病毒(I)蛋白酶抑制剂的3D-QSAR。III. CoMFA结果解读。
Drug Des Discov. 1994 Jul;12(1):29-51.

引用本文的文献

1
Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine.人工智能在药物发现与药物递送中的应用:变革个性化医疗
Pharmaceutics. 2024 Oct 14;16(10):1328. doi: 10.3390/pharmaceutics16101328.